< Back to latest news & events

News

HGF continues its European expansion with the opening of a new business in France

June 2021

HGF launched the next phase of its European expansion with the opening of its new business in France based in its 22nd European office, in Rennes, France. The office will be led by new partner, Vivien Verbrugge who joined the firm in February 2021. France is of strategic importance in HGF’s expansion in providing a pan-European intellectual property solution to its world-wide clients.

Paul Sanderson, CEO commented“HGF has always understood the importance of France for our plans of growth in Europe. A strategic decision was made based on the firm’s successes in Germany, The Netherlands, Switzerland and Ireland to open an office in Rennes, France. Our continued expansion reflects our commitment to providing the highest quality service both now and in the future across Europe.”

Vivien Verbrugge commented “I am delighted to be in the position to lead the firm’s growth in France and look forward to working with technology businesses across France and the rest of Europe. We have ambitious plans but I am confident of our success to support the firm’s international growth and development.”

Vivien’s wealth of experience as an in-house attorney, advising at Management and Board level within global companies in multiple jurisdictions, makes him well placed to advise in-house IP and Legal Counsel in relation to IP opportunities and threats for both SMEs and multinationals. Vivien regularly advises clients on portfolio creation, infringement avoidance and freedom to commercialise, portfolio enforcement and dispute resolution matters. Vivien has also advised on multi-jurisdiction portfolio acquisitions, secured successful outcomes in EPO oppositions and coordinated many IP litigations.

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article